Identification of Bach2 as a B-cell-specific partner for small maf proteins that negatively regulate the immunoglobulin heavy chain gene 3' enhancer.

PubWeight™: 2.13‹?› | Rank: Top 2%

🔗 View Article (PMC 1170901)

Published in EMBO J on October 01, 1998

Authors

A Muto1, H Hoshino, L Madisen, N Yanai, M Obinata, H Karasuyama, N Hayashi, H Nakauchi, M Yamamoto, M Groudine, K Igarashi

Author Affiliations

1: Department of Biochemistry, Tohoku University School of Medicine, Seiryo-machi, Aoba-ku, Sendai 980-8575, USA.

Articles citing this

Meta-analysis of genome-wide association study data identifies additional type 1 diabetes risk loci. Nat Genet (2008) 7.71

The selective autophagy substrate p62 activates the stress responsive transcription factor Nrf2 through inactivation of Keap1. Nat Cell Biol (2010) 6.95

Isolation of a novel histone deacetylase reveals that class I and class II deacetylases promote SMRT-mediated repression. Genes Dev (2000) 4.00

Stress-activated cap'n'collar transcription factors in aging and human disease. Sci Signal (2010) 3.19

Hemoprotein Bach1 regulates enhancer availability of heme oxygenase-1 gene. EMBO J (2002) 3.06

Influence of metabolism on epigenetics and disease. Cell (2013) 2.64

Heme mediates derepression of Maf recognition element through direct binding to transcription repressor Bach1. EMBO J (2001) 2.32

Heme regulates the dynamic exchange of Bach1 and NF-E2-related factors in the Maf transcription factor network. Proc Natl Acad Sci U S A (2004) 1.92

Critical residues within the BTB domain of PLZF and Bcl-6 modulate interaction with corepressors. Mol Cell Biol (2002) 1.70

Bach2 represses plasma cell gene regulatory network in B cells to promote antibody class switch. EMBO J (2010) 1.62

A GATA box in the GATA-1 gene hematopoietic enhancer is a critical element in the network of GATA factors and sites that regulate this gene. Mol Cell Biol (2000) 1.58

Molecular basis of electrophilic and oxidative defense: promises and perils of Nrf2. Pharmacol Rev (2012) 1.45

A combinatorial code for gene expression generated by transcription factor Bach2 and MAZR (MAZ-related factor) through the BTB/POZ domain. Mol Cell Biol (2000) 1.43

Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and gammaFBP-B. Proc Natl Acad Sci U S A (1999) 1.37

Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity. J Clin Invest (2008) 1.22

NRF2, cancer and calorie restriction. Oncogene (2010) 1.17

Microarray-based understanding of normal and malignant plasma cells. Immunol Rev (2006) 1.12

Functional studies of the BTB domain in the Drosophila GAGA and Mod(mdg4) proteins. Nucleic Acids Res (2000) 1.09

Bach2 maintains T cells in a naive state by suppressing effector memory-related genes. Proc Natl Acad Sci U S A (2013) 1.08

Transcription repressor Bach2 is required for pulmonary surfactant homeostasis and alveolar macrophage function. J Exp Med (2013) 1.03

Identification of novel Bach2 transcripts and protein isoforms through tagging analysis of retroviral integrations in B-cell lymphomas. BMC Mol Biol (2009) 1.02

Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease. PLoS Genet (2014) 1.01

Repression of PML nuclear body-associated transcription by oxidative stress-activated Bach2. Mol Cell Biol (2004) 0.99

Dual roles of NRF2 in tumor prevention and progression: possible implications in cancer treatment. Free Radic Biol Med (2014) 0.98

GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol (2013) 0.96

Identification of a novel erythroid-specific enhancer for the ALAS2 gene and its loss-of-function mutation which is associated with congenital sideroblastic anemia. Haematologica (2013) 0.95

Cooperative transcriptional repression by BCL6 and BACH2 in germinal center B-cell differentiation. Blood (2013) 0.93

Immunogenetics of autoimmune thyroid diseases: A comprehensive review. J Autoimmun (2015) 0.89

The membrane-topogenic vectorial behaviour of Nrf1 controls its post-translational modification and transactivation activity. Sci Rep (2013) 0.88

BACH2-BCL6 balance regulates selection at the pre-B cell receptor checkpoint. Trends Immunol (2013) 0.85

Nuclear translocation of B-cell-specific transcription factor, BACH2, modulates ROS mediated cytotoxic responses in mantle cell lymphoma. PLoS One (2013) 0.84

Regulation of Bach2 by the aryl hydrocarbon receptor as a mechanism for suppression of B-cell differentiation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2011) 0.84

Epigenetic Regulation of the Blimp-1 Gene (Prdm1) in B Cells Involves Bach2 and Histone Deacetylase 3. J Biol Chem (2016) 0.83

Transcription factor effector domains. Subcell Biochem (2011) 0.81

NFE2L2 pathway polymorphisms and lung function decline in chronic obstructive pulmonary disease. Physiol Genomics (2012) 0.81

Association between BACH2 expression and clinical prognosis in diffuse large B-cell lymphoma. Cancer Sci (2014) 0.80

Extensive gene-specific translational reprogramming in a model of B cell differentiation and Abl-dependent transformation. PLoS One (2012) 0.79

Oxidative stress regulates CFTR gene expression in human airway epithelial cells through a distal antioxidant response element. Am J Respir Cell Mol Biol (2015) 0.79

BACH2: a marker of DNA damage and ageing. DNA Repair (Amst) (2013) 0.78

Small Maf proteins (MafF, MafG, MafK): History, structure and function. Gene (2016) 0.78

All-or-none suppression of B cell terminal differentiation by environmental contaminant 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol Appl Pharmacol (2013) 0.78

Albumin-like proteins are critical regulators of vascular redox signaling. Oxid Med Cell Longev (2013) 0.75

Regulatory heme and trichloroethylene intoxication: A possible explanation of the case of "A Civil Action". Environ Health Prev Med (2002) 0.75

Increase of T and B cells and altered BACH2 expression patterns in bone marrow trephines of imatinib-treated patients with chronic myelogenous leukaemia. Oncol Lett (2016) 0.75

Plasma cells for hire: prior experience required. Immunity (2013) 0.75

BACH2 promotes indolent clinical presentation in Waldenström macroglobulinemia. Oncotarget (2016) 0.75

Articles cited by this

RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell (1992) 17.50

A new mouse myeloma cell line that has lost immunoglobulin expression but permits the construction of antibody-secreting hybrid cell lines. J Immunol (1979) 16.56

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res (1991) 13.54

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54

Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J Exp Med (1991) 10.87

Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A (1994) 6.72

Establishment and characterization of BALB/c lymphoma lines with B cell properties. J Immunol (1979) 6.70

Organization and reorganization of immunoglobulin genes in A-MULV-transformed cells: rearrangement of heavy but not light chain genes. Cell (1981) 6.31

Role of the histone deacetylase complex in acute promyelocytic leukaemia. Nature (1998) 5.63

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia. Nature (1998) 5.30

Multilineage gene expression precedes commitment in the hemopoietic system. Genes Dev (1997) 5.21

Immunoglobulin gene expression in transformed lymphoid cells. Proc Natl Acad Sci U S A (1983) 5.18

The proto-oncogene c-maf is responsible for tissue-specific expression of interleukin-4. Cell (1996) 5.13

Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper protein. Nature (1993) 4.68

Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature (1994) 4.20

Alterations of a zinc finger-encoding gene, BCL-6, in diffuse large-cell lymphoma. Science (1993) 3.89

Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol (1996) 3.72

Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J (1993) 3.58

The BTB/POZ domain: a new protein-protein interaction motif common to DNA- and actin-binding proteins. Cell Growth Differ (1995) 3.47

Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A (1993) 3.39

The effect of helper virus on Abelson virus-induced transformation of lymphoid cells. J Exp Med (1978) 3.25

Maf nuclear oncoprotein recognizes sequences related to an AP-1 site and forms heterodimers with both Fos and Jun. Mol Cell Biol (1994) 3.15

Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol (1995) 2.84

Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci U S A (1997) 2.82

A conserved retina-specific gene encodes a basic motif/leucine zipper domain. Proc Natl Acad Sci U S A (1992) 2.79

HDA1 and HDA3 are components of a yeast histone deacetylase (HDA) complex. J Biol Chem (1996) 2.71

The ubiquitous subunit of erythroid transcription factor NF-E2 is a small basic-leucine zipper protein related to the v-maf oncogene. Proc Natl Acad Sci U S A (1993) 2.63

Identification of the earliest B lineage stage in mouse bone marrow. Immunity (1996) 2.62

The Maf transcription factors: regulators of differentiation. Trends Biochem Sci (1997) 2.38

The world according to Maf. Nucleic Acids Res (1997) 2.30

Myc-Max-Mad: a transcription factor network controlling cell cycle progression, differentiation and death. Curr Opin Genet Dev (1994) 2.29

Molecular and cellular origins of B lymphocyte diversity. Cell (1991) 2.25

v-maf, a viral oncogene that encodes a "leucine zipper" motif. Proc Natl Acad Sci U S A (1989) 2.24

Purification of the human NF-E2 complex: cDNA cloning of the hematopoietic cell-specific subunit and evidence for an associated partner. Mol Cell Biol (1993) 2.05

Small Maf proteins heterodimerize with Fos and may act as competitive repressors of the NF-E2 transcription factor. Mol Cell Biol (1995) 1.97

Cloning and functional characterization of LCR-F1: a bZIP transcription factor that activates erythroid-specific, human globin gene expression. Nucleic Acids Res (1994) 1.93

Two new members of the maf oncogene family, mafK and mafF, encode nuclear b-Zip proteins lacking putative trans-activator domain. Oncogene (1993) 1.91

Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev (1994) 1.88

Cloning and functional characterization of early B-cell factor, a regulator of lymphocyte-specific gene expression. Genes Dev (1993) 1.84

MafB, a new Maf family transcription activator that can associate with Maf and Fos but not with Jun. Mol Cell Biol (1994) 1.77

A novel B-cell lineage-specific transcription factor present at early but not late stages of differentiation. Genes Dev (1990) 1.66

A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus. Nature (1990) 1.65

Multivalent DNA binding complex generated by small Maf and Bach1 as a possible biochemical basis for beta-globin locus control region complex. J Biol Chem (1998) 1.64

Human small Maf proteins form heterodimers with CNC family transcription factors and recognize the NF-E2 motif. Oncogene (1997) 1.50

Activity and expression of murine small Maf family protein MafK. J Biol Chem (1995) 1.46

Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene (1992) 1.46

Interaction of the CNC-bZIP factor TCF11/LCR-F1/Nrf1 with MafG: binding-site selection and regulation of transcription. Nucleic Acids Res (1998) 1.45

NF-HB (BSAP) is a repressor of the murine immunoglobulin heavy-chain 3' alpha enhancer at early stages of B-cell differentiation. Mol Cell Biol (1993) 1.43

Structure-function analysis of the maf oncogene product, a member of the b-Zip protein family. J Virol (1993) 1.43

Frequent lambda light chain gene rearrangement and expression in a Ly-1 B lymphoma with a productive kappa chain allele. Proc Natl Acad Sci U S A (1986) 1.42

An enhancer at the 3' end of the mouse immunoglobulin heavy chain locus. Nucleic Acids Res (1991) 1.38

Flow cytometry analysis of murine B cell lymphoma differentiation. Immunol Rev (1979) 1.37

Enhancer complexes located downstream of both human immunoglobulin Calpha genes. J Exp Med (1997) 1.35

Characterization of multiple immunoglobulin mu-chains synthesized by two clones of a B cell lymphoma. J Immunol (1980) 1.33

Molecular cloning of a putative novel human bZIP transcription factor on chromosome 17q22. Genomics (1994) 1.27

The immunoglobulin heavy chain locus contains another B-cell-specific 3' enhancer close to the alpha constant region. Mol Cell Biol (1993) 1.21

Conditional expression of the ubiquitous transcription factor MafK induces erythroleukemia cell differentiation. Proc Natl Acad Sci U S A (1995) 1.15

Transcription factors required for lymphoid lineage commitment. Curr Opin Immunol (1997) 1.13

Antigen-induced murine B cell lymphomas. I. Induction and characterization of CH1 and CH2. J Immunol (1978) 1.11

Mesodermal- vs. neuronal-specific expression of MafK is elicited by different promoters. Genes Cells (1996) 1.11

Palindromic structure of the IgH 3'locus control region. Nat Genet (1996) 1.05

IgM receptor-mediated transactivation of the IgH 3' enhancer couples a novel Elf-1-AP-1 protein complex to the developmental control of enhancer function. EMBO J (1995) 1.03

Human MafG is a functional partner for p45 NF-E2 in activating globin gene expression. Blood (1997) 1.00

Meticulous AP-1 factors. Nature (1994) 0.94

The enhancer shift: a model to explain the developmental control of IgH gene expression in B-lineage cells. Immunol Today (1997) 0.89

Regulation of gene expression at early stages of B-cell and T-cell differentiation. Curr Opin Immunol (1996) 0.80

Selective proliferation of lymphoid cells from lineage-c-Kit+ Sca-1+ cells by a clonal bone marrow stromal cell line. Exp Hematol (1998) 0.77

Articles by these authors

The transcriptional landscape of the mammalian genome. Science (2005) 37.63

Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 28.60

Chromosomal subunits in active genes have an altered conformation. Science (1976) 14.63

An Nrf2/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements. Biochem Biophys Res Commun (1997) 14.09

Essential Bacillus subtilis genes. Proc Natl Acad Sci U S A (2003) 14.01

Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain. Genes Dev (1999) 13.43

Tissue-specific DNA cleavages in the globin chromatin domain introduced by DNAase I. Cell (1980) 12.78

Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science (1996) 12.54

The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med (2001) 11.94

Confined lateral diffusion of membrane receptors as studied by single particle tracking (nanovid microscopy). Effects of calcium-induced differentiation in cultured epithelial cells. Biophys J (1993) 9.35

A third recognition element in bacterial promoters: DNA binding by the alpha subunit of RNA polymerase. Science (1993) 7.42

Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice. Nature (1996) 7.27

A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature (1986) 7.19

Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell (1998) 6.79

Sensitivity to carcinogenesis is increased and chemoprotective efficacy of enzyme inducers is lost in nrf2 transcription factor-deficient mice. Proc Natl Acad Sci U S A (2001) 6.78

Structural basis of glutamate recognition by a dimeric metabotropic glutamate receptor. Nature (2000) 6.58

Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis. Dig Dis Sci (1995) 6.36

Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol (1999) 6.15

Amplification of endogenous myc-related DNA sequences in a human myeloid leukaemia cell line. Nature (1982) 6.11

Large-scale analysis of gene function in Caenorhabditis elegans by high-throughput RNAi. Curr Biol (2001) 6.05

Characterization of a human immunodeficiency virus neutralizing monoclonal antibody and mapping of the neutralizing epitope. J Virol (1988) 5.96

Transcription factor Nrf2 coordinately regulates a group of oxidative stress-inducible genes in macrophages. J Biol Chem (2000) 5.75

Cyclin E-CDK2 is a regulator of p27Kip1. Genes Dev (1997) 5.49

A developmentally stable chromatin structure in the human beta-globin gene cluster. Proc Natl Acad Sci U S A (1986) 5.47

Evidence for a locus activation region: the formation of developmentally stable hypersensitive sites in globin-expressing hybrids. Nucleic Acids Res (1987) 5.46

The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res (1983) 5.41

Chromatin structure of endogenous retroviral genes and activation by an inhibitor of DNA methylation. Nature (1981) 5.39

Impaired glucose tolerance is a risk factor for cardiovascular disease, but not impaired fasting glucose. The Funagata Diabetes Study. Diabetes Care (1999) 5.37

Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem (1988) 5.22

Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme. Science (1997) 5.16

Enhanced transcription of c-myc in bursal lymphoma cells requires continuous protein synthesis. Science (1985) 5.08

Hb switching in chickens. Cell (1980) 4.88

Age-associated characteristics of murine hematopoietic stem cells. J Exp Med (2000) 4.65

Looping versus linking: toward a model for long-distance gene activation. Genes Dev (1999) 4.63

Control of c-myc regulation in normal and neoplastic cells. Adv Cancer Res (1991) 4.60

Alpha-Globin-gene switching during the development of chicken embryos: expression and chromosome structure. Cell (1981) 4.47

Ornithine decarboxylase is degraded by the 26S proteasome without ubiquitination. Nature (1992) 4.43

A giant nucleopore protein that binds Ran/TC4. Nature (1995) 4.36

Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature (1985) 4.35

Promoter-proximal pausing of RNA polymerase II defines a general rate-limiting step after transcription initiation. Genes Dev (1995) 4.30

A deletion of the human beta-globin locus activation region causes a major alteration in chromatin structure and replication across the entire beta-globin locus. Genes Dev (1990) 4.30

The block to transcriptional elongation within the human c-myc gene is determined in the promoter-proximal region. Genes Dev (1992) 4.20

Regulation of transcription by dimerization of erythroid factor NF-E2 p45 with small Maf proteins. Nature (1994) 4.20

The structure, expression, and properties of additional members of the protein kinase C family. J Biol Chem (1988) 4.15

Targeted deletion of 5'HS2 of the murine beta-globin LCR reveals that it is not essential for proper regulation of the beta-globin locus. Genes Dev (1995) 4.11

DNA banking: the effects of storage of blood and isolated DNA on the integrity of DNA. Am J Med Genet (1987) 4.09

Human fetal to adult hemoglobin switching: changes in chromatin structure of the beta-globin gene locus. Proc Natl Acad Sci U S A (1983) 4.05

High sensitivity of Nrf2 knockout mice to acetaminophen hepatotoxicity associated with decreased expression of ARE-regulated drug metabolizing enzymes and antioxidant genes. Toxicol Sci (2001) 4.02

Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell (1990) 3.98

Structure of the bacterial flagellar protofilament and implications for a switch for supercoiling. Nature (2001) 3.92

Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science (1993) 3.78

Proposal for a new clinical entity, IgG4-positive multiorgan lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis (2008) 3.77

Phosphatidylinositol 4,5-bisphosphate induces actin-based movement of raft-enriched vesicles through WASP-Arp2/3. Curr Biol (2000) 3.75

Bach proteins belong to a novel family of BTB-basic leucine zipper transcription factors that interact with MafK and regulate transcription through the NF-E2 site. Mol Cell Biol (1996) 3.72

Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J (1994) 3.60

The Cap'n'Collar basic leucine zipper transcription factor Nrf2 (NF-E2 p45-related factor 2) controls both constitutive and inducible expression of intestinal detoxification and glutathione biosynthetic enzymes. Cancer Res (2001) 3.57

Germline-specific expression of the Oct-4/green fluorescent protein (GFP) transgene in mice. Dev Growth Differ (1999) 3.56

Construction of YAC-based mammalian artificial chromosomes. Nat Biotechnol (1998) 3.55

Role of a ras homolog in the life cycle of Schizosaccharomyces pombe. Cell (1986) 3.54

Expression and function of c-kit in hemopoietic progenitor cells. J Exp Med (1991) 3.48

Massive Dirac fermion on the surface of a magnetically doped topological insulator. Science (2010) 3.46

Expression of the c-myb proto-oncogene during cellular proliferation. Nature (1986) 3.45

Enhancers increase the probability but not the level of gene expression. Proc Natl Acad Sci U S A (1995) 3.44

Turnover of cyclin E by the ubiquitin-proteasome pathway is regulated by cdk2 binding and cyclin phosphorylation. Genes Dev (1996) 3.40

Transcription elongation and eukaryotic gene regulation. Oncogene (1990) 3.34

Nuclear localization and histone acetylation: a pathway for chromatin opening and transcriptional activation of the human beta-globin locus. Genes Dev (2000) 3.27

Schizosaccharomyces pombe ste11+ encodes a transcription factor with an HMG motif that is a critical regulator of sexual development. Genes Dev (1991) 3.26

Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med (1998) 3.23

Protein kinase C zeta subspecies from rat brain: its structure, expression, and properties. Proc Natl Acad Sci U S A (1989) 3.21

Genetic organization of the bacterial conjugative transposon Tn916. J Bacteriol (1988) 3.18

Molecular analysis of the human beta-globin locus activation region. Proc Natl Acad Sci U S A (1989) 3.17

In vivo and in vitro stem cell function of c-kit- and Sca-1-positive murine hematopoietic cells. Blood (1992) 3.15

Host range mutant of human immunodeficiency virus type 1: modification of cell tropism by a single point mutation at the neutralization epitope in the env gene. J Virol (1991) 3.07

A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene. Cell Growth Differ (1996) 3.05

Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus. Structure (1999) 3.04

The dose dependence of glucocorticoid-inducible gene expression results from changes in the number of transcriptionally active templates. EMBO J (1990) 3.04

Beta-globin gene switching and DNase I sensitivity of the endogenous beta-globin locus in mice do not require the locus control region. Mol Cell (2000) 3.03

cDNA cloning and sequence analysis of beta ig-h3, a novel gene induced in a human adenocarcinoma cell line after treatment with transforming growth factor-beta. DNA Cell Biol (1992) 2.91

Nrf2-deficient female mice develop lupus-like autoimmune nephritis. Kidney Int (2001) 2.90

Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer. Mol Cell Biol (1991) 2.88

Mucosal adjuvant effect of cholera toxin in mice results from induction of T helper 2 (Th2) cells and IL-4. J Immunol (1995) 2.87

Sequence requirements for premature termination of transcription in the human c-myc gene. Cell (1988) 2.87

Cloning and characterization of a novel erythroid cell-derived CNC family transcription factor heterodimerizing with the small Maf family proteins. Mol Cell Biol (1995) 2.84

Flexible bronchofiberscope. Keio J Med (1968) 2.82

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4. Science (1991) 2.81

Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model. J Cell Physiol (1999) 2.77

Sequential alterations in the nuclear chromatin region during mitosis of the fission yeast Schizosaccharomyces pombe: video fluorescence microscopy of synchronously growing wild-type and cold-sensitive cdc mutants by using a DNA-binding fluorescent probe. J Cell Sci (1981) 2.75

The S.pombe mei2 gene encoding a crucial molecule for commitment to meiosis is under the regulation of cAMP. EMBO J (1988) 2.74

Qualitative comparison of carbon dioxide-induced change in cerebral near-infrared spectroscopy versus jugular venous oxygen saturation in adults with acute brain disease. Crit Care Med (1995) 2.74

Phorbol ester binding to protein kinase C requires a cysteine-rich zinc-finger-like sequence. Proc Natl Acad Sci U S A (1989) 2.72

Developmental defects of lymphoid cells in Jak3 kinase-deficient mice. Immunity (1995) 2.70